Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr775 Inhibitors

Olr775 inhibitors are a specialized class of chemical compounds that function by modulating the activity of the olfactory receptor 775 (Olr775), a member of the G-protein-coupled receptor (GPCR) family. Olr775 is part of a vast array of olfactory receptors responsible for detecting a diverse range of odorants in the environment, contributing to the sense of smell. These receptors, located on the olfactory epithelium in the nasal cavity, interact with odor molecules, initiating a signal transduction cascade that results in the perception of different smells. The inhibitors of Olr775 play a crucial role in modulating these sensory inputs by selectively binding to this receptor and altering its activity. This interaction can lead to changes in the receptor's conformation and signaling pathways, thereby affecting the overall olfactory response.

Chemically, Olr775 inhibitors exhibit a variety of structural motifs, reflecting the diversity of the ligands that can bind to olfactory receptors. These inhibitors are designed to fit into the binding pocket of Olr775, often utilizing hydrogen bonding, hydrophobic interactions, and Van der Waals forces to achieve high affinity and specificity. The structural design of these inhibitors can include a range of functional groups and molecular frameworks, such as heterocyclic rings, aromatic moieties, and aliphatic chains, which contribute to their binding properties. The study and development of Olr775 inhibitors involve extensive use of techniques such as X-ray crystallography, molecular docking, and computational modeling to understand the receptor-ligand interactions at a molecular level. This understanding helps in refining the inhibitors' design to enhance their efficacy and specificity, providing valuable insights into the intricate mechanisms of olfactory signaling and receptor modulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Targets BCR-ABL kinase, possibly affecting related signaling pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor, potentially influencing RAF/MEK/ERK signaling.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

BRAF inhibitor, potentially impacting the MAPK/ERK pathway.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Receptor tyrosine kinase inhibitor, potentially affecting angiogenesis pathways.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

JAK1/2 inhibitor, possibly influencing cytokine signaling pathways.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, potentially affecting apoptosis pathways.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

EGFR inhibitor, potentially affecting epidermal growth factor receptor signaling.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

mTOR inhibitor, potentially influencing cell growth and proliferation.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Bruton's tyrosine kinase inhibitor, possibly affecting B-cell receptor signaling.

Cobimetinib

934660-93-2sc-507421
5 mg
$270.00
(0)

MEK inhibitor, potentially impacting the MAPK/ERK pathway.